AI in Drug Discovery at a Glance The ongoing rise of artificial intelligence (AI) is significantly impacting various industries, with the pharmaceutical and biotech...
Lantern Pharma’s AI-driven drug discovery platform RADR® enables value creation across multiple dimensions of the oncology drug development process: from the expansion of therapeutic...
Community health system-based research continues to become an important focus area for pharmaceutical and medical device sponsors given the recent FDA guidance on diversity...
Stereotactic body radiation therapy (SBRT) is a precision cancer treatment that delivers fewer, higher-dose radiation fractions than traditional radiotherapy. SBRT can...